国药现代(600420.SH)：子公司通过药品GMP符合性检查

Core Viewpoint - The company, China National Pharmaceutical Group Modern (国药现代), announced that its wholly-owned subsidiary, China National Pharmaceutical Group Weichida Pharmaceutical Co., Ltd. (国药威奇达), has received a notice of compliance for Good Manufacturing Practice (GMP) inspection, indicating that the production lines in Workshop 108 and the comprehensive raw material pharmaceutical workshop have passed the GMP compliance check [1] Group 1 - The subsidiary, China National Pharmaceutical Group Weichida, has successfully passed the GMP compliance inspection [1] - The inspection covers specific production lines in Workshop 108 and the comprehensive raw material pharmaceutical workshop [1]